Who founded SynsoryBio?

SynsoryBio was founded by Elliot Tague, Nathan Tague in 2023.

Who are SynsoryBio's investors?

SynsoryBio's investors include Gurtin Ventures, Y Combinator, Agrolimen Ventures, Axial VC, Friends Family Capital, Phoenix Fund, Unpopular Ventures.

Where is SynsoryBio headquartered?

SynsoryBio is headquartered in Boston, US.

SynsoryBio

YC W24

Boston, US · Founded 2023 · 2 employees · 7 known investors

Find your way into SynsoryBio

Paths you didn't know you had: your email and LinkedIn already hold routes to the SynsoryBio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.

Biotech Healthtech Synthetic Biology Therapeutics OncologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W24)

SynsoryBio was founded in 2023 by Elliot Tague and Nathan Tague.

Elliot Tague FounderElliot Tague holds a PhD and has worked in synthetic biology and protein engineering, including time as a visiting graduate student in George Church's lab at Harvard and roles at various biotech startups.

Nathan Tague FounderNathan Tague holds a PhD in Biomedical Engineering and has expertise in synthetic biology and protein engineering. He is a co-founder of SynsoryBio, a therapeutics company developing sense-and-respond treatments.

Investors · 7

Gurtin Ventureslisted by Gurtin VenturesLa Jolla

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Axial VCreportedSan Francisco · $100K – $5M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Friends Family CapitalreportedSilicon Valley

How we know: Y Combinator's founder network · Not right? Tell us

Phoenix FundreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

Kopra BioKopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.

Eugit TherapeuticsTissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Modulari-TModulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

Serinus BiosciencesSerinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

Companies working in the same space as SynsoryBio.

Legal entities · 1

corporate structure

SynsoryBio, Inc.

In the news

SynsoryBio: Therapeutics that sense-and-respond to diseaseycombinator.com · Feb 2024

Frequently asked questions

What does SynsoryBio do?: SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Who founded SynsoryBio?: SynsoryBio was founded by Elliot Tague, Nathan Tague in 2023.
Who are SynsoryBio's investors?: SynsoryBio's investors include Gurtin Ventures, Y Combinator, Agrolimen Ventures, Axial VC, Friends Family Capital, Phoenix Fund, Unpopular Ventures.
Where is SynsoryBio headquartered?: SynsoryBio is headquartered in Boston, US.